SPLASH BEVERAGE GROUP, INC.
No SEC Form 4 filings for $SBEV in the last 30 days.
SPLASH BEVERAGE GROUP, INC. (SBEV) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 2 e7825_ex10-1.htm EXHIBIT 10.1 EXHIBIT 10.1 DEVELOPMENT AND COLLABORATION AGREEMENT This Development and Collaboration Agreement (this “Agreement” ) is entered into as of July 31, 2026 (the “Effective Date” ), by and between Splash Beverage Group, Inc. , a corporation du
Splash Beverage Group Inc. (NYSE:SBEV) shares are trending on Friday. Shares of the Florida-based company climbed 64.10% to $0.57 after the bell on Thursday. The surge in the late trading session follows an intraday gain of 7.07% which closed the SBEV at $0.35, according to Benzinga Pro data. Splash Beverage Group, which engages in the manufacturing, distribution, marketing, and sale of various beverages, experienced an exceptionally elevated trading session on Thursday.
SPLASH BEVERAGE GROUP, INC. (SBEV) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. false 0001553788 0001553788 2026-07-28 2026-07-28 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Repor
Over the past 7 days, alphai's AI scored 1 news story mentioning SBEV (SPLASH BEVERAGE GROUP, INC.). Coverage has been balanced: 0 bullish, 1 neutral, and 0 bearish.
Recent SBEV coverage spans corporate actions, financial news and technology.
The 8-K discloses a new collaboration framework where Lupvindol leads FDA regulatory work and Splash provides milestone funding and commercial support, which can change development timelines and funding needs.
The license expansion and planned veterinary JV are a near-term catalyst that can re-rate risk and valuation expectations for SBEV’s cannabinoid platform.
The addendum expands CannEpil’s monetizable scope (veterinary) and changes the royalty split, which can improve future revenue mix but is not quantified here.
The expanded license creates a new regulatory and commercialization pathway for CannEpil in veterinary oncology and pain management, but approval is uncertain.
Veterinary expansion creates a second regulated development track for CannEpil, potentially broadening addressable markets but with substantial regulatory and execution risk.
alphai scores every news story that mentions SBEV with an AI model for sentiment and relevance, and aggregates insider trades from SPLASH BEVERAGE GROUP, INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
SPLASH BEVERAGE GROUP, INC. (SBEV) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 2 e7825_ex10-1.htm EXHIBIT 10.1 EXHIBIT 10.1 DEVELOPMENT AND COLLABORATION AGREEMENT This Development and Collaboration Agreement (this “Agreement” ) is entered into as of July 31, 2026 (the “Effective Date” ), by and between Splash Beverage Group, Inc. , a corporation du
6 min readSplash Beverage Group Inc. (NYSE:SBEV) shares are trending on Friday. Shares of the Florida-based company climbed 64.10% to $0.57 after the bell on Thursday. The surge in the late trading session follows an intraday gain of 7.07% which closed the SBEV at $0.35, according to Benzinga Pro data. Splash Beverage Group, which engages in the manufacturing, distribution, marketing, and sale of various beverages, experienced an exceptionally elevated trading session on Thursday.
5 min readSPLASH BEVERAGE GROUP, INC. (SBEV) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. false 0001553788 0001553788 2026-07-28 2026-07-28 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Repor
4 min readSplash Beverage Group (SBEV) said it expanded its exclusive global license for CannEpil to cover veterinary therapeutic uses, including companion-animal oncology and pain management. CannEpil is an oral CBD/THC liquid. SBEV will pay Argent BioPharma a 10% royalty on net veterinary revenues and plans to seek FDA Center for Veterinary Medicine approval. No assurance of approval or commercialization. SBEV last traded at $0.3349, down 3.68% premarket.
3 min readSplash Beverage Group (NYSE American: SBEV) said it expanded its exclusive global CannEpil license to cover veterinary therapeutics. The company plans initial evaluation for companion-animal oncology and chronic pain, pursuing FDA Center for Veterinary Medicine INAD and Conditional Approval pathways. Splash will pay Argent BioPharma a 10% royalty on veterinary net revenues.
4 min readSPLASH BEVERAGE GROUP, INC. (SBEV) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. false 0001553788 0001553788 2026-07-15 2026-07-15 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Repor
4 min readSplash Beverage Group (NYSE American: SBEV) said it settled legacy creditor claims totaling about $3.3 million for about $550,000 cash, expecting an approximate $2.75 million gain from debt extinguishment, subject to final accounting. Its board approved a 1-for-4 reverse stock split to support NYSE American minimum price compliance, reducing shares from ~25.2M to ~6.3M, effective July 27, 2026.
4 min readSPLASH BEVERAGE GROUP, INC. (SBEV) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. false 0001553788 0001553788 2026-07-10 2026-07-10 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Repor
2 min readSPLASH BEVERAGE GROUP, INC. (SBEV) filed an SEC Form 8-K — Unregistered Sales of Equity Securities. false 0001553788 0001553788 2026-07-06 2026-07-06 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Repor
2 min readSplash Beverage Group (NYSE American: SBEV) said NYSE American accepted its plan to regain continued listing compliance and granted a compliance period through Jan. 29, 2027, after the company submitted the plan on May 29, 2026. The company said it will execute strategic initiatives while maintaining its listing.
3 min read
